查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552894

生物駭客市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場進行預測，2024-2030 年

Biohacking Market Size, Share & Trends Analysis Report By Product, By Application (Synthetic Biology, Drug Testing), By End-use (Hospitals & Clinics, Pharma & Biotech Companies), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

生物駭客市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球生物駭客市場規模將達到678.6億美元，2024年至2030年複合年成長率為18.6%。

市場參與者的各種措施和生物駭客資金的增加是推動市場成長的主要因素。採用生物駭客實踐可以幫助個人實現精神、身體和情緒的改變，例如降低疾病的風險，特別是遺傳相關疾病、減重和減少憂鬱症症狀，並改善身體健康，例如由於血壓升高而導致的血壓升高。

全球市場受到 COVID-19 大流行的嚴重影響。 COVID-19 對市場的主要影響包括供應鏈中斷、銷售下降和需求疲軟。然而，該行業的生物駭客正在投資研究工作來開發 COVID-19 疫苗和檢測套組。這抵消了 2020 年的市場成長。生物駭客購買設備和材料需要基本資金。除了群眾集資之外，這些機構的大部分活動都是透過會員費和研討會參加費自籌資金。此外，個人捐款也用於籌募資金。

睡眠改善與睡眠追蹤平台 Oura Ring 的製造商 Oura Health 於 2018 年 12 月在默沙東資本 (MSD Capital)主導的B 輪資金籌措中籌集了 2,000 萬美元。全球市場競爭相當激烈。大多數市場參與者正在實施新產品推出、收購和聯盟等策略，以獲得彼此的競爭優勢。例如，2020 年 9 月，蘋果與新加坡政府合作，利用 Apple Watch 發起了一項全國健康管理措施。為此，該國努力利用技術並為其公民提供先進的健康福利。

生物駭客市場報告亮點

  • 2023年穿戴領域佔29.9%。該市場當前的趨勢主要是由添加健康功能、結合人工智慧提供個人化提案以及向醫療保健專業人員發送即時資料以實現更快的干涉和更好的患者治療結果所驅動的。
  • 2023年，診斷和治療領域佔最大收益佔有率，超過32.3%。這是由於擴大使用生物駭客實踐，例如精神藥物和穿戴式技術來增強身體。
  • 2023年，醫院和診所部門佔最大佔有率，達40.3%。該領域的成長歸因於慢性病及其治療的增加。
  • 北美生物駭客市場在 2023 年以 36.7% 的市場佔有率佔據主導地位。這是由於慢性病盛行率不斷上升、生物駭客意識不斷增強以及該地區人口老化。
  • 亞太生物駭客市場預計到 2023 年將以 20.6% 的複合年成長率大幅成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章生物駭客市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 生物駭客市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 生物駭客市場：依產品估算與趨勢分析

  • 細分儀表板
  • 生物駭客市場：2023 年和 2030 年產品變化分析
  • 穿戴式的
  • 植入
  • 基因改造試劑套件
  • 聰明藥
  • 補充品
  • 行動應用程式
  • 其他

第5章生物駭客市場：按應用估計和趨勢分析

  • 細分儀表板
  • 生物駭客市場：2023 年和 2030 年應用變化分析
  • 合成生物學
  • 基因工程
  • 法醫學
  • 診斷和治療
  • 藥物測試

第6章生物駭客市場：區域估計與趨勢分析

  • 2023 年和 2030 年生物駭客市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Apple Inc.
    • THE ODIN
    • Thync Inc.
    • Fitbit, Inc.
    • Moodmetric
    • HVMN Inc.
    • Muse（Interaxon Inc.）
    • Thriveport, LLC
    • TrackMyStack
    • OsteoStrong
簡介目錄
Product Code: GVR-4-68039-479-7

Biohacking Market Growth & Trends:

The global biohacking market size is anticipated to reach USD 67.86 billion by 2030, registering a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Various initiatives by market players and rising funds for biohacking are the major factors fueling the market growth. The adoption of biohacking practices is growing due to their potential applications in decreasing the risk of developing a disease, especially genetically associated diseases, helping an individual to achieve mental, physical, or emotional changes, such as weight loss or reducing depression symptoms; and optimize general functions of the body, such as blood pressure.

The global market has been significantly affected by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, and low demand. However, biohackers in the industry are investing in some research activities for the development of COVID-19 vaccines as well as test kits. This neutralized the market growth in 2020. For the purchase of equipment and materials, biohackers require basic funding. Other than crowdfunding, most of the activities at these labs are self-funded through membership and workshop fees. Furthermore, private donations are also used for raising money.

Oura Health, manufacturer of the Oura ring, a sleep-improvement and sleep tracking platform, raised USD 20 million in Series B funding led by MSD Capital in December 2018. The global market is fairly competitive. Most of the market players have undertaken strategies, such as new product launches, acquisitions, and partnerships, to gain a competitive edge over each other. For instance, in September 2020, Apple Inc. partnered with the government of Singapore for launching a national health initiative using Apple Watch. With this, the country made an effort to leverage technology for delivering advanced health benefits to its citizens.

Biohacking Market Report Highlights:

  • The wearables segment accounted for a share of 29.9% in 2023. Current developments in this market mainly focus on technological progress, such as adding additional health functions, incorporating Artificial Intelligence for personalized suggestions, and sending live data to healthcare professionals for prompt interventions and better patient results.
  • The diagnosis and treatment segment held the largest revenue share of over 32.3% in 2023 due to the high usage of biohacking practices, such as nootropics and wearable technologies, for body enhancement purposes.
  • The hospitals and clinics segment held the largest share of 40.3% in 2023. The segment growth is credited to the increase in chronic diseases and their treatment.
  • North America biohacking market dominated the market in 2023 with a market share of 36.7%. This is due to the increasing prevalence of chronic illnesses, increase in the awareness of biohacking, and an aging population in the region.
  • Asia Pacific Biohacking market is anticipated to witness significant growth in 2023 with a CAGR of 20.6% attributing to the rise in healthcare expenditure that has led to economic growth in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biohacking Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biohacking Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biohacking Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biohacking Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Wearables
    • 4.3.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Wearable Neurotech
    • 4.3.2. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.1. Oura ring
    • 4.3.3. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.1. Muse Headband
    • 4.3.4. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.1. Others
  • 4.4. Implants
    • 4.4.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Blood test Implants
    • 4.4.2. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.1. Circadia Implants
    • 4.4.3. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.1. NFC and RFID tags
    • 4.4.4. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.1. Others
  • 4.5. Gene Modification Kits
    • 4.5.1. Gene Modification Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Smart Drugs
    • 4.6.1. Smart Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Supplements
    • 4.7.1. Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Mobile Apps
    • 4.8.1. Mobile Apps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biohacking Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biohacking Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Synthetic Biology
    • 5.3.1. Synthetic Biology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Genetic Engineering
    • 5.4.1. Genetic Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Forensic Science
    • 5.5.1. Forensic Science Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnosis & Treatment
    • 5.6.1. Diagnosis & Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Drug Testing
    • 5.7.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biohacking Market: Regional Estimates & Trend Analysis

  • 6.1. Biohacking Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. UAE Biohacking Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Apple Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. THE ODIN
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Thync Inc.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Fitbit, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Moodmetric
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. HVMN Inc.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Muse (Interaxon Inc.)
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Thriveport, LLC
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. TrackMyStack
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. OsteoStrong
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiative